DARPA Awards Inflammatix Up to $1.1M for Diagnostic to Predict Covid-19 Severity
Inflammatix, Burlingame, Calif, a pioneering molecular diagnostics company, announced that the...
Read More
Search Results for: covid-19
GenMark’s ePlex Respiratory Pathogen Panel 2 Receives FDA EUA
The RP2 Panel provides results in less than 2 hours for more than 20 viruses and bacteria that cause common respiratory infections with similar symptoms, including covid-19, flu, bronchitis and the common cold.
Read More
FDA EUA for Quidel’s Rapid Antigen “ABC Test” for Influenza A and B and Covid-19
The Sofia 2 Flu + SARS Antigen FIA point-of-care test delivers three results from one sample in 15 minutes.
Read More
LabCorp Covid-19 Molecular Test Innovation Gets FDA EUA
LabCorp’s new, high-throughput method uses heat and technology to extract RNA from samples collected for covid-19 molecular testing.
Read More
Qiagen to Launch QIAprep& Viral RNA UM Kit
The novel kit combines a liquid-based sample preparation step completed in 2 minutes with real-time PCR detection in a streamlined workflow.
Read More